BioAdaptives Financial Statements From 2010 to 2025
| BDPT Stock | USD 0.04 0.02 72.73% |
Check BioAdaptives financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAdaptives' main balance sheet or income statement drivers, such as , as well as many indicators such as . BioAdaptives financial statements analysis is a perfect complement when working with BioAdaptives Valuation or Volatility modules.
BioAdaptives |
BioAdaptives Company Shares Outstanding Analysis
BioAdaptives' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BioAdaptives Shares Outstanding | 160.49 M |
Most of BioAdaptives' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioAdaptives is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, BioAdaptives has 160.49 M of shares currently outstending. This is 61.46% lower than that of the Consumer Defensive sector and 38.08% lower than that of the Packaged Foods industry. The shares outstanding for all United States stocks is 71.93% higher than that of the company.
BioAdaptives Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioAdaptives's current stock value. Our valuation model uses many indicators to compare BioAdaptives value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioAdaptives competition to find correlations between indicators driving BioAdaptives's intrinsic value. More Info.BioAdaptives is rated below average in return on asset category among its peers. It is rated fifth in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioAdaptives' earnings, one of the primary drivers of an investment's value.About BioAdaptives Financial Statements
BioAdaptives shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioAdaptives investors may analyze each financial statement separately, they are all interrelated. The changes in BioAdaptives' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioAdaptives' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.